Skip to main content

Vincristine sulfate liposome injection

Details of the Drug
Generic Name:
Vincristine sulfate liposome injection
vin-KRIS-teen SUHL-feyt
Drug Type:
How the Drug is Given:

Intravenously (IV) (fatal if given by other routes)

Vincristine sulfate liposome injection

Indications and Usage

Vincristine sulfate liposome injection is FDA approved for the treatment of adult patients with Philadelphia chromosome-negative (Ph-) acute lymphoblastic leukemia (ALL) in second or greater relapse or whose disease has progressed following two or more anti-leukemia therapies.

Side effects needing medical attention

Constipation; bowel obstruction; nausea; fever; fatigue; diarrhea; decreased appetite; insomnia; low blood cell counts; pneumonia; life-threatening low blood pressure; infection; peripheral sensory and motor neuropathy; lack of strength; muscular weakness; respiratory distress; respiratory failure; pain; abdominal pain; hypotension; mental status changes; cardiac arrest.  

For information on how to manage the costs of drug therapy, please see Financial Support, or to speak with an Information Specialist, call (800) 955-4572.